234 related articles for article (PubMed ID: 14655194)
1. Acute effect of pamidronate on PTH secretion in postmenopausal hemodialysis patients with secondary hyperparathyroidism.
Lu KC; Yeung LK; Lin SH; Lin YF; Chu P
Am J Kidney Dis; 2003 Dec; 42(6):1221-7. PubMed ID: 14655194
[TBL] [Abstract][Full Text] [Related]
2. Effects of pamidronate and calcitriol on the set point of the parathyroid gland in postmenopausal hemodialysis patients with secondary hyperparathyroidism.
Huang CY; Zheng CM; Wu CC; Lo L; Lu KC; Chu P
Nephron Clin Pract; 2012; 122(3-4):93-101. PubMed ID: 23635416
[TBL] [Abstract][Full Text] [Related]
3. The PTH-calcium curve and the set point of calcium in primary and secondary hyperparathyroidism.
Malberti F; Farina M; Imbasciati E
Nephrol Dial Transplant; 1999 Oct; 14(10):2398-406. PubMed ID: 10528664
[TBL] [Abstract][Full Text] [Related]
4. Hysteresis of the parathyroid hormone response to hypocalcemia in hemodialysis patients with low turnover aluminum bone disease.
Felsenfeld AJ; Ross D; Rodriguez M
J Am Soc Nephrol; 1991 Dec; 2(6):1136-43. PubMed ID: 1777594
[TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
6. Calcitriol and the parathyroid hormone-ionized calcium curve: a comparison of methodologic approaches.
Ouseph R; Leiser JD; Moe SM
J Am Soc Nephrol; 1996 Mar; 7(3):497-505. PubMed ID: 8704117
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of intravenous calcitriol therapy on the control of secondary hyperparathyroidism.
Malberti F; Corradi B; Cosci P; Calliada F; Marcelli D; Imbasciati E
Am J Kidney Dis; 1996 Nov; 28(5):704-12. PubMed ID: 9158208
[TBL] [Abstract][Full Text] [Related]
8. Effect of CAPD and hemodialysis on parathyroid function.
Malberti F; Corradi B; Imbasciati E
Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid function as a determinant of the response to calcitriol treatment in the hemodialysis patient.
Rodriguez M; Caravaca F; Fernandez E; Borrego MJ; Lorenzo V; Cubero J; Martin-Malo A; Betriu A; Jimenez A; Torres A; Felsenfeld AJ
Kidney Int; 1999 Jul; 56(1):306-17. PubMed ID: 10411707
[TBL] [Abstract][Full Text] [Related]
10. Differences in the dynamics of parathyroid hormone secretion in hemodialysis patients with marked secondary hyperparathyroidism.
Felsenfeld AJ; Jara A; Pahl M; Bover J; Rodriguez M
J Am Soc Nephrol; 1995 Nov; 6(5):1371-8. PubMed ID: 8589311
[TBL] [Abstract][Full Text] [Related]
11. Acute effects of repetitive hemodialysis on circulating immunoreactive parathyroid hormone levels in uremic patients undergoing vitamin D (calcitriol) therapy.
Bellazzi R; Romanini D; Bacchella L; Nai M; Aprile C; Santagostino M; De Vincenzi A
Nephron; 1991; 57(3):273-82. PubMed ID: 2017266
[TBL] [Abstract][Full Text] [Related]
12. The sigmoidal parathyroid hormone-ionized calcium curve and the set point of calcium in hemodialysis and continuous ambulatory peritoneal dialysis.
Malberti F; Corradi B; Pagliari B; Romanini D; Gazo A; Sidoti A; Baretta A; Bellazzi R; Imbasciati E
Perit Dial Int; 1993; 13 Suppl 2():S476-9. PubMed ID: 8399645
[TBL] [Abstract][Full Text] [Related]
13. Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis.
Dunlay R; Rodriguez M; Felsenfeld AJ; Llach F
Kidney Int; 1989 Dec; 36(6):1093-8. PubMed ID: 2601258
[TBL] [Abstract][Full Text] [Related]
14. PTH secretion in patients with chronic renal failure assessed by a modified CiCa clamp method: effects of 1-year calcitriol therapy.
Schindler S; Mannstadt M; Urena P; Segre GV; Stein G
Clin Nephrol; 2004 Apr; 61(4):253-60. PubMed ID: 15125031
[TBL] [Abstract][Full Text] [Related]
15. Different effects of calcitriol and parathyroidectomy on the PTH-calcium curve in dialysis patients with severe hyperparathyroidism.
Malberti F; Corradi B; Cosci P; Colecchia M; Leopardi O; Grossi L; Oldini C; Imbasciati E
Nephrol Dial Transplant; 1996 Jan; 11(1):81-7. PubMed ID: 8649657
[TBL] [Abstract][Full Text] [Related]
16. A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism.
Goodman WG; Frazao JM; Goodkin DA; Turner SA; Liu W; Coburn JW
Kidney Int; 2000 Jul; 58(1):436-45. PubMed ID: 10886592
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of PTH secretion in hemodialysis patients as determined by the intact and whole PTH assays.
Santamaria R; Almaden Y; Felsenfeld A; Martin-Malo A; Gao P; Cantor T; Aljama P; Rodriguez M
Kidney Int; 2003 Nov; 64(5):1867-73. PubMed ID: 14531822
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of pamidronate in severe secondary hyperparathyroidism in patients undergoing hemodialysis.
Torregrosa JV; Moreno A; Mas M; Ybarra J; Fuster D
Kidney Int Suppl; 2003 Jun; (85):S88-90. PubMed ID: 12753274
[TBL] [Abstract][Full Text] [Related]
19. Calcium-regulated parathyroid hormone release in patients with mild or advanced secondary hyperparathyroidism.
Goodman WG; Belin T; Gales B; Juppner H; Segre GV; Salusky IB
Kidney Int; 1995 Nov; 48(5):1553-8. PubMed ID: 8544413
[TBL] [Abstract][Full Text] [Related]
20. Altered instantaneous and calcium-modulated oscillatory PTH secretion patterns in patients with secondary hyperparathyroidism.
Schmitt CP; Huber D; Mehls O; Maiwald J; Stein G; Veldhuis JD; Ritz E; Schaefer F
J Am Soc Nephrol; 1998 Oct; 9(10):1832-44. PubMed ID: 9773784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
